Compare UEC & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UEC | BCPC |
|---|---|---|
| Founded | 2003 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Major Chemicals |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.3B |
| IPO Year | 2008 | 1995 |
| Metric | UEC | BCPC |
|---|---|---|
| Price | $8.27 | $169.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | $16.03 | ★ $209.25 |
| AVG Volume (30 Days) | ★ 8.6M | 173.7K |
| Earning Date | 09-29-2026 | 10-23-2026 |
| Dividend Yield | N/A | ★ 0.57% |
| EPS Growth | N/A | ★ 20.87 |
| EPS | N/A | ★ 2.63 |
| Revenue | $37,250,000.00 | ★ $799,023,000.00 |
| Revenue This Year | $70.84 | $9.11 |
| Revenue Next Year | $178.50 | $5.67 |
| P/E Ratio | ★ N/A | $63.95 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $8.81 | $142.00 |
| 52 Week High | $20.34 | $183.90 |
| Indicator | UEC | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 31.19 | 55.39 |
| Support Level | N/A | $159.79 |
| Resistance Level | $10.31 | $176.62 |
| Average True Range (ATR) | 0.43 | 3.21 |
| MACD | -0.05 | 0.60 |
| Stochastic Oscillator | 5.68 | 92.01 |
Uranium Energy Corp is engaged in uranium mining and related activities, including exploration, permitting, pre-extraction, extraction, recovery, and processing. The Company undertakes conventional and ISR uranium extraction and recovery and the exploration, permitting, and evaluation of uranium properties in the United States, Canada, and the Republic of Paraguay. Its principal projects are located in Wyoming and Texas in the United States and Saskatchewan, Canada. The Company operates three hub-and-spoke platforms in South Texas and Wyoming, anchored by licensed CPPs and served by ISR and conventional uranium projects. Its operating segments consist of uranium exploration and mining activities in Wyoming, Texas, Saskatchewan, and others, with Wyoming generating maximum revenue.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.